Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 200

1.

Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.

Ogura A, Konishi T, Beets GL, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Rutten HJT, Tuynman JB, Kusters M; Lateral Node Study Consortium.

JAMA Surg. 2019 Jul 3:e192172. doi: 10.1001/jamasurg.2019.2172. [Epub ahead of print]

PMID:
31268504
2.

Significant improvement in postoperative and 1-year mortality after colorectal cancer surgery in recent years.

Ketelaers SHJ, Orsini RG, Burger JWA, Nieuwenhuijzen GAP, Rutten HJT.

Eur J Surg Oncol. 2019 Jun 13. pii: S0748-7983(19)30511-6. doi: 10.1016/j.ejso.2019.06.017. [Epub ahead of print]

PMID:
31255442
3.

Inter-hospital variation in resection rates of colon cancer in the Netherlands: A nationwide study.

Giesen LJX, van Erning FN, Vissers PAJ, Maas HAAM, Rutten HJT, Lemmens VEPP, Dekker JWT.

Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30506-2. doi: 10.1016/j.ejso.2019.06.012. [Epub ahead of print]

PMID:
31202571
4.

The gap in postoperative outcome between older and younger patients with stage I-III colorectal cancer has been bridged; results from the Netherlands cancer registry.

Brouwer NPM, Heil TC, Olde Rikkert MGM, Lemmens VEPP, Rutten HJT, de Wilt JHW, van Erning FN.

Eur J Cancer. 2019 Jul;116:1-9. doi: 10.1016/j.ejca.2019.04.036. Epub 2019 Jun 1.

PMID:
31163335
5.

Colonoscopy Surveillance After Colorectal Cancer: the Optimal Interval for Follow-Up.

Ramphal W, Boeding JRE, Schreinemakers JMJ, Gobardhan PD, Rutten HJT, Crolla RMPH.

J Gastrointest Cancer. 2019 Jun 3. doi: 10.1007/s12029-019-00254-5. [Epub ahead of print]

PMID:
31155695
6.

Time trends of short-term mortality for octogenarians undergoing a colorectal resection in North Europe.

Claassen YHM, Bastiaannet E, van Eycken E, Van Damme N, Martling A, Johansson R, Iversen LH, Ingeholm P, Lemmens VEPP, Liefers GJ, Holman FA, Dekker JWT, Portielje JEA, Rutten HJ, van de Velde CJH.

Eur J Surg Oncol. 2019 Apr 9. pii: S0748-7983(19)30386-5. doi: 10.1016/j.ejso.2019.03.041. [Epub ahead of print]

PMID:
31003722
7.

Definition of the Rectum: An International, Expert-based Delphi Consensus.

DʼSouza N, de Neree Tot Babberich MPM, d'Hoore A, Tiret E, Xynos E, Beets-Tan RGH, Nagtegaal ID, Blomqvist L, Holm T, Glimelius B, Lacy A, Cervantes A, Glynne-Jones R, West NP, Perez RO, Quadros C, Lee KY, Madiba TE, Wexner SD, Garcia-Aguilar J, Sahani D, Moran B, Tekkis P, Rutten HJ, Tanis PJ, Wiggers T, Brown G.

Ann Surg. 2019 Apr 8. doi: 10.1097/SLA.0000000000003251. [Epub ahead of print]

PMID:
30973385
8.

Prognostic impact of repeat sentinel lymph node biopsy in patients with ipsilateral breast tumour recurrence.

Poodt IGM, Vugts G, Schipper RJ, Roumen RMH, Rutten HJT, Maaskant-Braat AJG, Voogd AC, Nieuwenhuijzen GAP; Sentinel Node and Recurrent Breast Cancer (SNARB) study group.

Br J Surg. 2019 Apr;106(5):574-585. doi: 10.1002/bjs.11097.

PMID:
30908615
9.

Serum carcinoembryonic antigen to predict recurrence in the follow-up of patients with colorectal cancer.

Ramphal W, Boeding JRE, van Iwaarden M, Schreinemakers JMJ, Rutten HJT, Crolla RMPH, Gobardhan PD.

Int J Biol Markers. 2019 Mar;34(1):60-68. doi: 10.1177/1724600818820679. Epub 2019 Mar 11.

PMID:
30852955
10.

The association between body mass index and postoperative complications, 30-day mortality and long-term survival in Dutch patients with colorectal cancer.

Arkenbosch JHC, van Erning FN, Rutten HJ, Zimmerman D, de Wilt JHW, Beijer S.

Eur J Surg Oncol. 2019 Feb;45(2):160-166. doi: 10.1016/j.ejso.2018.09.012. Epub 2018 Oct 16.

PMID:
30712552
11.

Oncologic outcome and recurrence rate following anastomotic leakage after curative resection for colorectal cancer.

Ramphal W, Boeding JRE, Gobardhan PD, Rutten HJT, de Winter LJMB, Crolla RMPH, Schreinemakers JMJ.

Surg Oncol. 2018 Dec;27(4):730-736. doi: 10.1016/j.suronc.2018.10.003. Epub 2018 Oct 10.

PMID:
30449500
12.

Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.

Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S, Lee IK, Lee HX, Uehara K, Lee P, Putter H, van de Velde CJH, Beets GL, Rutten HJT, Kusters M; Lateral Node Study Consortium.

J Clin Oncol. 2019 Jan 1;37(1):33-43. doi: 10.1200/JCO.18.00032. Epub 2018 Nov 7.

13.

Optimal management of localized rectal cancer in older patients.

Bujko K, Glynne-Jones R, Papamichael D, Rutten HJT.

J Geriatr Oncol. 2018 Nov;9(6):696-704. doi: 10.1016/j.jgo.2018.08.001. Epub 2018 Aug 24.

PMID:
30150020
14.

Prognostic implications of MRI-detected lateral nodal disease and extramural vascular invasion in rectal cancer.

Schaap DP, Ogura A, Nederend J, Maas M, Cnossen JS, Creemers GJ, van Lijnschoten I, Nieuwenhuijzen GAP, Rutten HJT, Kusters M.

Br J Surg. 2018 Dec;105(13):1844-1852. doi: 10.1002/bjs.10949. Epub 2018 Aug 6.

PMID:
30079958
15.

Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison.

Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E.

Br J Cancer. 2018 Aug;119(4):517-522. doi: 10.1038/s41416-018-0215-6. Epub 2018 Jul 30.

PMID:
30057408
16.

Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania.

Breugom AJ, Bastiaannet E, Boelens PG, Van Eycken E, Iversen LH, Martling A, Johansson R, Evans T, Lawton S, O'Brien KM, Ortiz H, Janciauskiene R, Dekkers OM, Rutten HJT, Liefers GJ, Lemmens VEPP, van de Velde CJH.

Eur J Surg Oncol. 2018 Sep;44(9):1338-1343. doi: 10.1016/j.ejso.2018.05.025. Epub 2018 May 26.

PMID:
29960770
17.

The Effect of Myopenia on the Inflammatory Response Early after Colorectal Surgery.

Smeets BJJ, Brinkman DJ, Horsten ECJ, Langius JAE, Rutten HJT, de Jonge WJ, Luyer MDP.

Nutr Cancer. 2018 Apr;70(3):460-466. doi: 10.1080/01635581.2018.1445763. Epub 2018 Mar 14.

PMID:
29537903
18.

Major influence of postoperative complications on costs of cytoreductive surgery and HIPEC in patients with colorectal peritoneal metastases.

Simkens GA, Rovers KP, van Oudheusden TR, Nienhuijs SW, Rutten HJ, de Hingh IH.

Medicine (Baltimore). 2018 Mar;97(10):e0042. doi: 10.1097/MD.0000000000010042.

19.

Perioperative lipid-enriched enteral nutrition versus standard care in patients undergoing elective colorectal surgery (SANICS II): a multicentre, double-blind, randomised controlled trial.

Peters EG, Smeets BJJ, Nors J, Back CM, Funder JA, Sommer T, Laurberg S, Løve US, Leclercq WKG, Slooter GD, de Vries Reilingh TS, Wegdam JA, Nieuwenhuijzen GAP, Hiligsmann M, Buise MP, Buurman WA, de Jonge WJ, Rutten HJT, Luyer MDP.

Lancet Gastroenterol Hepatol. 2018 Apr;3(4):242-251. doi: 10.1016/S2468-1253(18)30031-1. Epub 2018 Feb 14.

PMID:
29426699
20.

Health-related quality of life and cost-effectiveness analysis of gum chewing in patients undergoing colorectal surgery: results of a randomized controlled trial.

Pattamatta M, Smeets BJJ, Evers SMAA, Rutten HJT, Luyer MDP, Hiligsmann M.

Acta Chir Belg. 2018 Oct;118(5):299-306. doi: 10.1080/00015458.2018.1432742. Epub 2018 Jan 30.

PMID:
29378476
21.

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

Boogerd LSF, Hoogstins CES, Schaap DP, Kusters M, Handgraaf HJM, van der Valk MJM, Hilling DE, Holman FA, Peeters KCMJ, Mieog JSD, van de Velde CJH, Farina-Sarasqueta A, van Lijnschoten I, Framery B, Pèlegrin A, Gutowski M, Nienhuijs SW, de Hingh IHJT, Nieuwenhuijzen GAP, Rutten HJT, Cailler F, Burggraaf J, Vahrmeijer AL.

Lancet Gastroenterol Hepatol. 2018 Mar;3(3):181-191. doi: 10.1016/S2468-1253(17)30395-3. Epub 2018 Jan 30.

PMID:
29361435
22.

Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer.

van Zoggel DMGI, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, Cnossen JS, Creemers GJ, van Lijnschoten G, Rutten HJT.

Br J Surg. 2018 Mar;105(4):447-452. doi: 10.1002/bjs.10694. Epub 2017 Nov 23.

PMID:
29168556
23.

Treatment and Outcome of Synchronous Colorectal Carcinomas: A Nationwide Study.

Bos ACRK, Matthijsen RA, van Erning FN, van Oijen MGH, Rutten HJT, Lemmens VEPP.

Ann Surg Oncol. 2018 Feb;25(2):414-421. doi: 10.1245/s10434-017-6255-y. Epub 2017 Nov 20.

PMID:
29159744
24.

Psoas hitch ureteral reimplantation after surgery for locally advanced and locally recurrent colorectal cancer: Complications and oncological outcome.

van den Heijkant F, Vermeer TA, Vrijhof EJEJ, Nieuwenhuijzen GAP, Koldewijn EL, Rutten HJT.

Eur J Surg Oncol. 2017 Oct;43(10):1869-1875. doi: 10.1016/j.ejso.2017.05.018. Epub 2017 May 26.

PMID:
28732671
25.

Effect of Early vs Late Start of Oral Intake on Anastomotic Leakage Following Elective Lower Intestinal Surgery: A Systematic Review.

Smeets BJJ, Peters EG, Horsten ECJ, Weijs TJ, Rutten HJT, Buurman WA, de Jonge WJ, Luyer MDP.

Nutr Clin Pract. 2018 Dec;33(6):803-812. doi: 10.1177/0884533617711128. Epub 2017 Dec 14.

PMID:
28628353
26.

Short-Course Radiotherapy Followed by Neoadjuvant Bevacizumab, Capecitabine, and Oxaliplatin and Subsequent Radical Treatment in Primary Stage IV Rectal Cancer: Long-Term Results of a Phase II Study.

Bisschop C, van Dijk TH, Beukema JC, Jansen RLH, Gelderblom H, de Jong KP, Rutten HJT, van de Velde CJH, Wiggers T, Havenga K, Hospers GAP.

Ann Surg Oncol. 2017 Sep;24(9):2632-2638. doi: 10.1245/s10434-017-5897-0. Epub 2017 May 30.

27.

Results of intraoperative electron beam radiotherapy containing multimodality treatment for locally unresectable T4 rectal cancer: a pooled analysis of the Mayo Clinic Rochester and Catharina Hospital Eindhoven.

Holman FA, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, van den Berg HA, Nelson H, Rutten HJ.

J Gastrointest Oncol. 2016 Dec;7(6):903-916. doi: 10.21037/jgo.2016.07.01.

28.

Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC.

Simkens GA, van Oudheusden TR, Nieboer D, Steyerberg EW, Rutten HJ, Luyer MD, Nienhuijs SW, de Hingh IH.

Ann Surg Oncol. 2016 Dec;23(13):4214-4221. Epub 2016 Mar 30.

PMID:
27027308
29.

Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study).

Musters GD, Klaver CEL, Bosker RJI, Burger JWA, van Duijvendijk P, van Etten B, van Geloven AAW, de Graaf EJR, Hoff C, Leijtens JWA, Rutten HJT, Singh B, Vuylsteke RJCLM, de Wilt JHW, Dijkgraaf MGW, Bemelman WA, Tanis PJ.

Ann Surg. 2017 Jun;265(6):1074-1081. doi: 10.1097/SLA.0000000000002020.

PMID:
27768621
30.

Short-term outcome in patients treated with cytoreduction and HIPEC compared to conventional colon cancer surgery.

Simkens GA, Verwaal VJ, Lemmens VE, Rutten HJ, de Hingh IH.

Medicine (Baltimore). 2016 Oct;95(41):e5111.

31.

Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: Results of 565 patients of two major treatment centres.

Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, van den Berg H, Nelson H, Rutten HJ.

Eur J Surg Oncol. 2017 Jan;43(1):107-117. doi: 10.1016/j.ejso.2016.08.015. Epub 2016 Sep 9.

PMID:
27659000
32.

No Difference in Overall Survival Between Hospital Volumes for Patients With Colorectal Cancer in The Netherlands.

Bos AC, van Erning FN, Elferink MA, Rutten HJ, van Oijen MG, de Wilt JH, Lemmens VE.

Dis Colon Rectum. 2016 Oct;59(10):943-52. doi: 10.1097/DCR.0000000000000660.

PMID:
27602925
33.

Axillary reverse mapping in axillary surgery for breast cancer: an update of the current status.

Beek MA, Gobardhan PD, Schoenmaeckers EJ, Klompenhouwer EG, Rutten HJ, Voogd AC, Luiten EJ.

Breast Cancer Res Treat. 2016 Aug;158(3):421-32. doi: 10.1007/s10549-016-3920-y. Epub 2016 Jul 21. Review.

PMID:
27444925
34.

Clinicopathological characteristics predict lymph node metastases in ypT0-2 rectal cancer after chemoradiotherapy.

Bosch SL, Vermeer TA, West NP, Swellengrebel HA, Marijnen CA, Cats A, Verhoef C, van Lijnschoten I, de Wilt JH, Rutten HJ, Nagtegaal ID.

Histopathology. 2016 Nov;69(5):839-848. doi: 10.1111/his.13008. Epub 2016 Jul 26.

35.

Delaying surgery after neoadjuvant chemoradiotherapy does not significantly influence postoperative morbidity or oncological outcome in patients with oesophageal adenocarcinoma.

Kathiravetpillai N, Koëter M, van der Sangen MJ, Creemers GJ, Luyer MD, Rutten HJ, Nieuwenhuijzen GA.

Eur J Surg Oncol. 2016 Aug;42(8):1183-90. doi: 10.1016/j.ejso.2016.03.033. Epub 2016 Apr 19.

PMID:
27134188
36.

Cytoreductive surgery and HIPEC offers similar outcomes in patients with rectal peritoneal metastases compared to colon cancer patients: a matched case control study.

Simkens GA, van Oudheusden TR, Braam HJ, Wiezer MJ, Nienhuijs SW, Rutten HJ, van Ramshorst B, de Hingh IH.

J Surg Oncol. 2016 Apr;113(5):548-53. doi: 10.1002/jso.24169. Epub 2016 Jan 12.

PMID:
27110701
37.

Histological subtype and systemic metastases strongly influence treatment and survival in patients with synchronous colorectal peritoneal metastases.

Simkens GA, Razenberg LG, Lemmens VE, Rutten HJ, Creemers GJ, de Hingh IH.

Eur J Surg Oncol. 2016 Jun;42(6):794-800. doi: 10.1016/j.ejso.2016.03.014. Epub 2016 Mar 28.

PMID:
27055946
38.

Increased Survival of Patients with Synchronous Colorectal Peritoneal Metastases Receiving Preoperative Chemotherapy Before Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Devilee RA, Simkens GA, van Oudheusden TR, Rutten HJ, Creemers GJ, Ten Tije AJ, de Hingh IH.

Ann Surg Oncol. 2016 Sep;23(9):2841-8. doi: 10.1245/s10434-016-5214-3. Epub 2016 Apr 4.

PMID:
27044447
39.

Beneficial Effects of Early Enteral Nutrition After Major Rectal Surgery: A Possible Role for Conditionally Essential Amino Acids? Results of a Randomized Clinical Trial.

van Barneveld KW, Smeets BJ, Heesakkers FF, Bosmans JW, Luyer MD, Wasowicz D, Bakker JA, Roos AN, Rutten HJ, Bouvy ND, Boelens PG.

Crit Care Med. 2016 Jun;44(6):e353-61. doi: 10.1097/CCM.0000000000001640.

PMID:
26937858
40.

Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy.

Beek MA, Tetteroo E, Luiten EJ, Gobardhan PD, Rutten HJ, Heijns JB, Voogd AC, Klompenhouwer EG.

Eur J Surg Oncol. 2016 May;42(5):672-8. doi: 10.1016/j.ejso.2016.02.005. Epub 2016 Feb 10.

PMID:
26898838
41.

Local Recurrence in the Lateral Lymph Node Compartment: Improved Outcomes with Induction Chemotherapy Combined with Multimodality Treatment.

Kusters M, Bosman SJ, Van Zoggel DM, Nieuwenhuijzen GA, Creemers GJ, Van den Berg HA, Rutten HJ.

Ann Surg Oncol. 2016 Jun;23(6):1883-9. doi: 10.1245/s10434-016-5098-2. Epub 2016 Feb 2.

PMID:
26842492
42.

Biopsychosocial predictors of sexual function and quality of sexual life: a study among patients with colorectal cancer.

Traa MJ, Roukema JA, De Vries J, Rutten HJ, Langenhoff B, Jansen W, Den Oudsten BL.

Transl Androl Urol. 2015 Apr;4(2):206-17. doi: 10.3978/j.issn.2223-4683.2015.03.01. Review.

43.

Two decades of axillary management in breast cancer.

Beek MA, Verheuvel NC, Luiten EJ, Klompenhouwer EG, Rutten HJ, Roumen RM, Gobardhan PD, Voogd AC.

Br J Surg. 2015 Dec;102(13):1658-64. doi: 10.1002/bjs.9955.

PMID:
26694991
44.

Stoma placement in obstructive rectal cancer prior to neo-adjuvant treatment and definitive surgery: A practical guideline.

Vermeer TA, Orsini RG, Nieuwenhuijzen GA, Rutten HJ, Daams F.

Eur J Surg Oncol. 2016 Feb;42(2):273-80. doi: 10.1016/j.ejso.2015.11.008. Epub 2015 Nov 22.

PMID:
26681383
45.

Determinants in decision making for curative treatment and survival in patients with resectable oesophageal cancer in the Netherlands: a population-based study.

Koëter M, van Steenbergen LN, Lemmens VE, Rutten HJ, Roukema JA, Nieuwenhuijzen GA.

Cancer Epidemiol. 2015 Dec;39(6):863-9. doi: 10.1016/j.canep.2015.10.007. Epub 2015 Nov 9.

PMID:
26651448
46.

Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis.

Simkens GA, van Oudheusden TR, Luyer MD, Nienhuijs SW, Nieuwenhuijzen GA, Rutten HJ, de Hingh IH.

Ann Surg Oncol. 2016 Mar;23(3):833-41. doi: 10.1245/s10434-015-4892-6. Epub 2015 Oct 6.

PMID:
26442921
47.

Effect of adjuvant chemotherapy on recurrence-free survival varies by neo-adjuvant treatment in patients with stage III rectal cancer.

van Erning FN, Rutten HJ, van den Berg HA, Lemmens VE, van Halteren HK.

Eur J Surg Oncol. 2015 Dec;41(12):1630-5. doi: 10.1016/j.ejso.2015.09.011. Epub 2015 Sep 26.

PMID:
26437853
48.

Understanding the surgical pitfalls in total mesorectal excision: Investigating the histology of the perirectal fascia and the pelvic autonomic nerves.

Kraima AC, West NP, Treanor D, Magee DR, Bleys RL, Rutten HJ, van de Velde CJ, Quirke P, DeRuiter MC.

Eur J Surg Oncol. 2015 Dec;41(12):1621-9. doi: 10.1016/j.ejso.2015.08.166. Epub 2015 Sep 16.

49.

The anatomy of the perineal body in relation to abdominoperineal excision for low rectal cancer.

Kraima AC, West NP, Treanor D, Magee D, Roberts N, van de Velde CJ, DeRuiter MC, Quirke P, Rutten HJ.

Colorectal Dis. 2016 Jul;18(7):688-95. doi: 10.1111/codi.13138.

50.

Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer.

Vugts G, Maaskant-Braat AJ, Voogd AC, van Riet YE, Luiten EJ, Rutgers EJ, Rutten HJ, Roumen RM, Nieuwenhuijzen GA.

Breast Cancer Res Treat. 2015 Oct;153(3):549-56. doi: 10.1007/s10549-015-3571-4. Epub 2015 Sep 10.

PMID:
26358709

Supplemental Content

Loading ...
Support Center